Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Revolutionary new test to help eliminate Tuberculosis


A revolutionary new test for identifying people infected with tuberculosis (TB), one of the leading causes of death worldwide, will shortly be launched by Oxford Immunotec Ltd, a new Oxford University spin-off company. The test radically improves the speed and accuracy with which the disease can be identified. It has been developed to replace the existing skin test for TB, which is given to 600,000 UK schoolchildren every year.

Oxford Immunotec’s test has come from discoveries made over the last seven years at the University of Oxford by Dr Ajit Lalvani and collaborators at the Nuffield Department of Medicine, John Radcliffe Hospital. A replacement for the 100-year-old skin test is long overdue but, until now, there has not been a better way of diagnosing infection.
The Oxford Immunotec test is based on patented technology which provides a simple and extremely accurate way of studying a person’s cellular immune response to an infection. Every time someone becomes infected with a disease, the body produces specific cells (white blood cells) to fight the infection. The new test looks to see if the body has produced these cells in response to TB and monitors how their numbers change over time. In this way, it is possible to determine if a person is infected and whether they are effectively fighting the infection. This powerful technique can be used not only for diagnosis of infections, but also for prognosis of disease and monitoring of treatment.

Crucially, the Oxford Immunotec test will also make it possible to accurately identify people who are carrying TB infection, but who have not yet gone on to develop disease. Diagnosing and treating infected people before they go on to develop severe disease and infect others is essential to prevent the spread of TB and save lives. TB kills between two and three million people each year, and the death toll is increasing. TB in the UK has risen almost every year for the last 15 years, with 6,500 newly diagnosed cases each year.

Since 1998, Dr Lalvani has used this rapid blood test in double blinded, randomised studies to prove its effectiveness in over 2,000 TB patients and healthy controls in eight different countries. These studies demonstrate that the new test is a radical improvement on the current skin test, and that, unlike the skin test, it works well in people with weaker immune systems, such as children, the elderly and those immunosuppressed with diseases like HIV.

Dr Peter Wrighton-Smith, CEO of Oxford Immunotec, said: ’We are extremely excited about this new test which we believe will revolutionise TB control. This test is needed as never before because TB is resurging in the developed world and already parts of the UK have TB rates as high as India. The huge amount of clinical data gathered to date proves this technology works and we are already looking to apply it to other diseases where the cellular immune response is critical, such as HIV, Hepatitis C and Cancer.’

Barbara Hott | alfa

More articles from Health and Medicine:

nachricht Inflammation Triggers Unsustainable Immune Response to Chronic Viral Infection
24.10.2016 | Universität Basel

nachricht Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

Im Focus: Ultra-thin ferroelectric material for next-generation electronics

'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.

Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

New method increases energy density in lithium batteries

24.10.2016 | Power and Electrical Engineering

International team discovers novel Alzheimer's disease risk gene among Icelanders

24.10.2016 | Life Sciences

New bacteria groups, and stunning diversity, discovered underground

24.10.2016 | Life Sciences

More VideoLinks >>>